Press Releases

Month Year

Month Year

Apr 2, 2014

Insmed Announces Leadership Team Transitions and Appointments to Expand Support for Growth Opportunities

Read more
Mar 26, 2014

Insmed Announces Results from Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacterial Lung Infections

Conference Call with Insmed Management and Clinical Trial Investigators Will be Held Today at 8:00 a.m. Eastern Time

Read more
Mar 25, 2014

Insmed to Announce Results From U.S. Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacteria Lung Infections

Read more
Mar 6, 2014

Insmed Reports 2013 Fourth Quarter and Full Year Financial Results

Read more
Feb 19, 2014

Insmed Provides Interim Update from Two-Year, Open-Label Extension Study of ARIKACE to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients

Initial 12-Month Data Demonstrate Long-Term Safety and Durability of Effect

Read more
Feb 10, 2014

ARIKACE to Receive Orphan Medicinal Product Designation in the European Union to Treat Lung Infections Caused by Nontuberculous Mycobacteria

Read more
Feb 4, 2014

Insmed to Present at the Leerink Swann Global Healthcare Conference

Read more
Feb 4, 2014

Insmed to Present at the Leerink Swann Global Healthcare Conference

Read more
Nov 5, 2013

Insmed Reports Third Quarter 2013 Financial Results

Read more
Nov 1, 2013

Insmed Appoints David W.J. McGirr to Its Board of Directors

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation